Pierre Corvol
Photo: Postaire, CC BY-SA 4.0, via Wikimedia Commons17

Pierre Corvol

French doctor and biology researcher (born 1941)

Pierre Corvol (born 18 August 1941) is a French doctor and biology researcher. He was director of the Collège de France from 2006 to August 2012.2

From Wikipedia’s article on Pierre Corvol (this version), CC BY-SA 4.0.

Born Aug 18, 1941.1

Companies

Early life and education

  • Date not recordedLycée Fénelon Sainte-Marie3
  • Date not recordedLycée Condorcet3

Corvol studied at the Lycée Condorcet in Paris, France. He served as resident at academic hospitals of Paris (1964), and spent post-doctoral research at the National Institutes of Health in Bethesda, Maryland, USA, in 1969.

From Wikipedia’s article on Pierre Corvol (this version), CC BY-SA 4.0.

Career

Occupation: researcher, physiologist, professor, physician.5 11

  • Since 2020Chair, Fondation Singer-Polignac10
  • 2019 to 2020President of the French Academy of Sciences7 8
  • 2019 to 2020Chair, French Academy of Sciences9
  • 2006 to 2012Director of the Collège de France7
  • Date not recordedWorked at French National Institute of Health and Medical Research4 5
  • Date not recordedProfessor, Collège de France4
  • Date not recordedBoard member, Fondation Singer-Polignac6

Scientific career

He became an associate professor at CHU Broussais Hôtel-Dieu in 1976. In 1983, he took over the management of Inserm's U36 (Vascular Pathology and Renal Endocrinology) and was elected as the chairman of the experimental medicine department at the Collège de France in 1989, a position he held until 2012. He was director of the Collège de France from 2006 to August 2012, and was succeeded by Serge Haroche.

Corvol is a researcher in the field of endocrine regulation of blood pressure and hypertension. In particular, he was one of the discoverers of the hormone regulatory system, the renin angiotensin system, and the angiotensin converting enzyme.

His work contributes to the development of therapeutics blocking the renin-angiotensin-aldosterone system. These drugs are widely used in the treatment of high blood pressure, heart failure and kidney failure in diabetics. He was a pioneer of the genetics of high blood pressure in humans. He has shown the importance of genetic markers in the renin system for predisposition to hypertension, cardiovascular disease and renal complications in diabetics.

Read more

Professional activities

Corvol chaired the Scientific Council of the Foundation for Medical Research (1995-1998), the Scientific Council of Inserm (1999-2003), the Board of Directors of the École normale supérieure (2001-2004), and the Scientific Council of the Assistance public-Hôpitaux de Paris (2004-2006). He was a member of Inserm's Scientific Steering Committee from 1985 to 1992 and played a major role in the creation of Clinical Investigation Centres (1990-1992), which allowed clinical research in hospitals.

In 2016, he was commissioned by Thierry Mandon to report on scientific integrity, which encouraged a series of measures for scientific integrity in France, including the creation of the French Office for Scientific Integrity in 2017.

From Wikipedia’s article on Pierre Corvol (this version), CC BY-SA 4.0.

Personal life

  • BornAug 18, 1941, Boulogne-Billancourt12
  • CitizenshipFrance13

Awards

  • 2016Grand Officer of the National Order of Merit14
  • 2012honorary doctor of Semmelweis University14
  • 2008Commander of the Legion of Honour14
  • 2006Honorary doctorate from the University of Geneva14
  • 2006Inserm Grand Prix14 15
  • 1997Honorary doctor of the University of Lausanne14
  • 1993Gay-Lussac-Humboldt-Prize14
  • 1993Officer of the National Order of Merit14